Usefulness of glycosylated ferritin in atypical presentations of adult onset Still's disease
Article Abstract:
Two case reports are discussed in this study, one of an 80-year-old woman and the other of a 51-year-old woman. Both are detected with atypical presentations of adult onset Still's disease, both of which are discussed.
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 2004
United States, Science & research, Research, Case studies, Rheumatic diseases, Dosage and administration, Ferritin
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women
Article Abstract:
The characteristics of the haemolysis, elevated liver enzymes, low platelets syndrome in the antiphospholipid syndrome and its influence on the subsequent pregnancies are examined.
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 2005
France, Medical examination, Pregnant women, Antiphospholipid syndrome
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: Diagnosis
Similar abstracts:
- Abstracts: Power and socialisation. Partners for the future
- Abstracts: Pain relief in palliative care. Opioids for the management of persistent non-cancer pain. Patient - controlled analgesia after coronary artery bypass grafting
- Abstracts: Increased midtrimester amniotic fluid activin A: a risk factor for subsequent fetal death. Elevated maternal midtrimester serum free beta-human chrionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results
- Abstracts: Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody. Getting to the guts of NOD2
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.